Skip to content
SCIINV Website Logo transparent
  • Home
  • Who We Are
    • About Us
    • Team
    • Advisory Board
    • Partners
  • What We Do
    • AMR Diagnostics
      • AMRx®
    • AMR Therapeutics
    • AMR Lab
  • How We Work
    • Drug Discovery Platforms
      • AMRx® De novo
      • AMRx® Drug Repurposing
  • Patents
  • Contact us
  • Home
  • Who We Are
    • About Us
    • Team
    • Advisory Board
    • Partners
  • What We Do
    • AMR Diagnostics
      • AMRx®
    • AMR Therapeutics
    • AMR Lab
  • How We Work
    • Drug Discovery Platforms
      • AMRx® De novo
      • AMRx® Drug Repurposing
  • Patents
  • Contact us
  • March 23, 2026

Pioneering the Fight Against AMR: The Rise of SCIINV Biosciences


Know More

PrevPreviousHyderabad-based startup to begin human clinical trials for India’s first AI-driven antibiotic
Linkedin Facebook X-twitter
Who We Are
  • About Us
  • Our Team
  • Our Scientific Advisory Board
  • Our Partners & Collaborators
  • About Us
  • Our Team
  • Our Scientific Advisory Board
  • Our Partners & Collaborators
What We Do
  • AMRx®
  • AMR Lab
  • AMR Therapeutics
  • AMRx®
  • AMR Lab
  • AMR Therapeutics
How We Work
  • AMRx® Drug Repurposing
  • AMRx® De novo
  • AMRx® Drug Repurposing
  • AMRx® De novo
  • Patents
  • Blogs
  • Contact us
  • © 2025 SCIINV. All Rights Reserved
  • Privacy Policy
  • Terms of Use